Baxter Halts Production of Heparin
By THOMAS M. BURTON and JON KAMP February 12, 2008
Baxter International Inc. temporarily suspended production of the widely used
blood-thinner heparin because of about 350 possible allergic reactions,
including four deaths, primarily in patients undergoing kidney dialysis and
heart surgery.
Because heparin, a generic drug available for decades, is widely used in
hospitals and dialysis centers, Baxter said it isn't suspending sales of the
heparin already produced. Officials of the Food and Drug Administration made
that decision along with executives of Baxter, of Deerfield, Ill., to avoid
shortages.
...
Heparin is derived from pig intestines.
Leaving a possibly tainted product on the market required an agonizing
balancing act by the FDA, and will mean more balancing by kidney specialists,
heart doctors and others who use the product.
rest:
http://online.wsj.com/article/SB120275413037059379.html?mod=hps_us_whats_news